Interfering with PD-1-PD-L1/PD-L2 interaction has been proposed as a method of counteracting immunosuppression in sepsis, and animal models have shown positive results in terms of immune cell function and survival [22, 23]. This evidence concerns the gene PDCD1LG2 and Sepsis.